E

Evotec SE
XETRA:EVT

Watchlist Manager
Evotec SE
XETRA:EVT
Watchlist
Price: 8.46 EUR -5.1% Market Closed
Market Cap: 1.5B EUR
Have any thoughts about
Evotec SE?
Write Note

Evotec SE
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Evotec SE
Cost of Revenue Peer Comparison

Comparables:
GXI
1SXP

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
E
Evotec SE
XETRA:EVT
Cost of Revenue
-€662.4m
CAGR 3-Years
-17%
CAGR 5-Years
-13%
CAGR 10-Years
-28%
Gerresheimer AG
XETRA:GXI
Cost of Revenue
-€1.4B
CAGR 3-Years
-12%
CAGR 5-Years
-7%
CAGR 10-Years
-4%
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Cost of Revenue
-€582.1m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Evotec SE's Cost of Revenue?
Cost of Revenue
-662.4m EUR

Based on the financial report for Jun 30, 2024, Evotec SE's Cost of Revenue amounts to -662.4m EUR.

What is Evotec SE's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-28%

Over the last year, the Cost of Revenue growth was -13%. The average annual Cost of Revenue growth rates for Evotec SE have been -17% over the past three years , -13% over the past five years , and -28% over the past ten years .

Back to Top